CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ·Healthcare·Biotechnology
$0.30
-4.34%
Mkt Cap $8.01M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$12.50
Range $11.00 – $14.00
Implied Upside
+4009.1%
Consensus $12.50 vs current $0.30
NASDAQ·Healthcare·Biotechnology
$0.30
-4.34%
Mkt Cap $8.01M
No recent rating data.
Price Target (2 analysts)
$12.50
Range $11.00 – $14.00
+4009.1%
Consensus $12.50 vs current $0.30